17 research outputs found
Content-based image retrieval system for marine invertebrates
There are many marine life around the world where it is essential to have proper documentation for future records. Many information retrieval systems for marine science today require text input from user and can only be accessed online. Therefore, people who do not know the name of the marine species or do not have Internet access cannot search using the systems. Responding to this important need, this work aims to develop a Content-based Image Retrieval (CBIR) system for marine invertebrates based on colour and shape features. With the CBIR system for marine invertebrates, users can use the system to look for marine invertebrates' species instead of using traditional methods of searching such as using books and encyclopedias. Users can easily upload the image of marine invertebrate that they want to search into the system and the system will retrieve all the other similar images of marine invertebrates along with their description. All the system interface's buttons, icons and text were designed in a way where any user can easily understand and further learn to operate the system themselves. Based on the retrieval effectiveness experiment and questionnaire-based survey, the proposed CBIR system for marine invertebrates is shown to be effective, help users search similar images of marine invertebrates, provide concise information on marine invertebrate's species for learning purposes, and is reliable and user-friendly
Content-based feature fusion representation for marine invertebrates
Marine species representation and retrieval is crucial for its studies and conservation. The images of these animals are usually captured underwater with complex background, at different angle, position, and size, which makes it very hard to provide a good representation with the current methods. Most of the current methods only support content-based representation for marine life images with clear background (taken in laboratory or in environments which have been set up), containing just one animal in an image, or the animal is positioned nicely at the centre of the image. Responding to these important needs, a multi-feature method for Content-based Image Retrieval (CBIR) that employs colour, shape, and texture information of marine life images is proposed. The colour feature vectors are obtained by extracting first and second order of Colour Moments. Shape information is constructed through the implementation of Discrete Wavelet transform up to four sub-bands and the extraction of Canny edge feature. Texture features are obtained with the Zernike Moments (ZM) of order four and the extraction of few Grey Level Co-occurrence Matrix properties. We conducted two experiments to determine the best order of ZM as well as to measure the retrieval performance of the proposed descriptor. Retrieval results based on marine invertebrate and Fish4Knowledge datasets clearly shown that the proposed method has effectively obtained the best precision value at 11 standard recall levels (72.42%) and MAP value (67.7%). The proposed method is further measured based on the statistical two-tailed paired t-test and has revealed a significant improvement in retrieval effectiveness
Induction of cell cycle arrest and apoptosis by copper complex Cu(SBCM)â towards oestrogen-receptor positive MCF-7 breast cancer cells
Copper complexes have the potential to be developed as targeted therapy for cancer because cancer cells take up larger amounts of copper than normal cells. Copper complex Cu(SBCM)2 has been reported to induce cell cycle arrest and apoptosis towards triple-negative breast cancer cells. Nevertheless, its effect towards other breast cancer subtypes has not been explored. Therefore, the present study was conducted to investigate the effect of Cu(SBCM)â towards oestrogen-receptor positive MCF-7 breast cancer cells. Growth inhibition of Cu(SBCM)â towards MCF-7 and human non-cancerous MCF-10A breast cells was determined by MTT assay. Morphological changes of Cu(SBCM)2-treated-MCF-7 cells were observed under an inverted microscope. Annexin V/PI apoptosis assay and cell cycle analysis were evaluated by flow cytometry. The expression of wild-type p53 protein was evaluated by Western blot analysis. The intracellular ROS levels of MCF-7 treated with Cu(SBCM)â were detected using DCFH-DA under a fluorescence microscope. The cells were then co-treated with Cu(SBCM)â and antioxidants to evaluate the involvement of ROS in the cytotoxicity of Cu(SBCM)2. Docking studies of Cu(SBCM)2 with DNA, DNA topoisomerase I, and human ribonucleotide reductase were also performed. The growth of MCF-7 cells was inhibited by Cu(SBCM)2 in a dose-dependent manner with less toxicity towards MCF-10A cells. It was found that Cu(SBCM)â induced G2/M cell cycle arrest and apoptosis in MCF-7 cells, possibly via a p53 pathway. Induction of intracellular ROS was not detected in MCF-7 cells. Interestingly, antioxidants enhance the cytotoxicity of Cu(SBCM)2 towards MCF-7 cells. DNA topoisomerase I may be the most likely target that accounts for the cytotoxicity of Cu(SBCM)â
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
dentification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 x 10(-8)) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.Peer reviewe
Recommended from our members
Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments.
ImportanceFor critically ill patients with advanced medical illnesses and poor prognoses, overuse of invasive intensive care unit (ICU) treatments may prolong suffering without benefit.ObjectiveTo examine whether use of time-limited trials (TLTs) as the default care-planning approach for critically ill patients with advanced medical illnesses was associated with decreased duration and intensity of nonbeneficial ICU care.Design, setting, and participantsThis prospective quality improvement study was conducted from June 1, 2017, to December 31, 2019, at the medical ICUs of 3 academic public hospitals in California. Patients at risk for nonbeneficial ICU treatments due to advanced medical illnesses were identified using categories from the Society of Critical Care Medicine guidelines for admission and triage.InterventionsClinicians were trained to use TLTs as the default communication and care-planning approach in meetings with family and surrogate decision makers.Main outcomes and measuresQuality of family meetings (process measure) and ICU length of stay (clinical outcome measure).ResultsA total of 209 patients were included (mean [SD] age, 63.6 [16.3] years; 127 men [60.8%]; 101 Hispanic patients [48.3%]), with 113 patients (54.1%) in the preintervention period and 96 patients (45.9%) in the postintervention period. Formal family meetings increased from 68 of 113 (60.2%) to 92 of 96 (95.8%) patients between the preintervention and postintervention periods (Pâ<â.01). Key components of family meetings, such as discussions of risks and benefits of ICU treatments (preintervention, 15 [34.9%] vs postintervention, 56 [94.9%]; Pâ<â.01), eliciting values and preferences of patients (20 [46.5%] vs 58 [98.3%]; Pâ<â.01), and identifying clinical markers of improvement (9 [20.9%] vs 52 [88.1%]; Pâ<â.01), were discussed more frequently after intervention. Median ICU length of stay was significantly reduced between preintervention and postintervention periods (8.7 [interquartile range (IQR), 5.7-18.3] days vs 7.4 [IQR, 5.2-11.5] days; Pâ=â.02). Hospital mortality was similar between the preintervention and postintervention periods (66 of 113 [58.4%] vs 56 of 96 [58.3%], respectively; Pâ=â.99). Invasive ICU procedures were used less frequently in the postintervention period (eg, mechanical ventilation preintervention, 97 [85.8%] vs postintervention, 70 [72.9%]; Pâ=â.02).Conclusions and relevanceIn this study, a quality improvement intervention that trained physicians to communicate and plan ICU care with family members of critically ill patients in the ICU using TLTs was associated with improved quality of family meetings and a reduced intensity and duration of ICU treatments. This study highlights a patient-centered approach for treating critically ill patients that may reduce nonbeneficial ICU care.Trial registrationClinicalTrials.gov Identifier: NCT04181294
Recommended from our members
Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial.
Introduction: We conducted a randomized controlled trial evaluating the efficacy and tolerability of cryotherapy in preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with early breast cancer receiving neo/adjuvant weekly paclitaxel. Methods: Patients were recruited from the National Cancer Centre Singapore and randomized (1:1) to receive either cryotherapy or usual care. Cryotherapy was applied as frozen gloves and socks on all extremities from 15 min before paclitaxel until 15 min post-infusion every cycle. Efficacy was measured by patient-reported outcomes (Patient Neurotoxicity Questionnaire [PNQ] and EORTC QLQ-CIPN20) and electrophysiological assessments. The primary endpoint was PNQ severity at 2 weeks after 12 cycles of weekly paclitaxel. Results: A total of 46 patients were recruited, of which 8 dropped out before paclitaxel treatment, leaving 38 evaluable. There was no significant difference in PNQ severity between cryotherapy and usual care at 2 weeks after paclitaxel treatment (sensory: p = 0.721; motor: p = 1.000). A benefit was observed at 3 months post-paclitaxel based on PNQ (sensory: 14.3 vs. 41.2%, p = 0.078; motor: 0 vs. 29.4%, p = 0.012) and CIPN20 (sensory: ÎČ = -3.6, 95%CI = -10.5-3.4, p = 0.308; motor: ÎČ = -7.3, 95%CI = -14.6-0, p = 0.051). Additionally, cryotherapy subjects have lower CIPN20 autonomic score (ÎČ = -5.84, 95%CI = -11.15 to -0.524, p = 0.031) and higher sympathetic skin response hand amplitudes (ÎČ = 0.544, 95%CI = 0.108-0.98, p = 0.014), suggesting possible autonomic benefits from cryotherapy. Temporary interruption with cryotherapy occurred in 80.9% of the subjects due to cold intolerance. Conclusions: There is insufficient evidence that cryotherapy prevents sensory neuropathy which may be due to the high rates of cryotherapy interruption in this study. The autonomic benefits of cryotherapy should be further investigated with appropriate outcome measures. Clinical Trial Registration: ClinicalTrials.gov: NCT03429972
Recommended from our members
Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial.
Introduction: We conducted a randomized controlled trial evaluating the efficacy and tolerability of cryotherapy in preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with early breast cancer receiving neo/adjuvant weekly paclitaxel. Methods: Patients were recruited from the National Cancer Centre Singapore and randomized (1:1) to receive either cryotherapy or usual care. Cryotherapy was applied as frozen gloves and socks on all extremities from 15 min before paclitaxel until 15 min post-infusion every cycle. Efficacy was measured by patient-reported outcomes (Patient Neurotoxicity Questionnaire [PNQ] and EORTC QLQ-CIPN20) and electrophysiological assessments. The primary endpoint was PNQ severity at 2 weeks after 12 cycles of weekly paclitaxel. Results: A total of 46 patients were recruited, of which 8 dropped out before paclitaxel treatment, leaving 38 evaluable. There was no significant difference in PNQ severity between cryotherapy and usual care at 2 weeks after paclitaxel treatment (sensory: p = 0.721; motor: p = 1.000). A benefit was observed at 3 months post-paclitaxel based on PNQ (sensory: 14.3 vs. 41.2%, p = 0.078; motor: 0 vs. 29.4%, p = 0.012) and CIPN20 (sensory: ÎČ = -3.6, 95%CI = -10.5-3.4, p = 0.308; motor: ÎČ = -7.3, 95%CI = -14.6-0, p = 0.051). Additionally, cryotherapy subjects have lower CIPN20 autonomic score (ÎČ = -5.84, 95%CI = -11.15 to -0.524, p = 0.031) and higher sympathetic skin response hand amplitudes (ÎČ = 0.544, 95%CI = 0.108-0.98, p = 0.014), suggesting possible autonomic benefits from cryotherapy. Temporary interruption with cryotherapy occurred in 80.9% of the subjects due to cold intolerance. Conclusions: There is insufficient evidence that cryotherapy prevents sensory neuropathy which may be due to the high rates of cryotherapy interruption in this study. The autonomic benefits of cryotherapy should be further investigated with appropriate outcome measures. Clinical Trial Registration: ClinicalTrials.gov: NCT03429972
A common variant mapping to <i>CACNA1A </i>is associated with susceptibility to exfoliation syndrome
Author manuscript available from PMC http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605818/Exfoliation syndrome (XFS) is the most common recognizable
cause of open-angle glaucoma worldwide. To better understand
the etiology of XFS, we conducted a genome-wide association
study (GWAS) of 1,484 cases and 1,188 controls from Japan
and followed up the most significant findings in a further
6,901 cases and 20,727 controls from 17 countries across
6 continents. We discovered a genome-wide significant
association between a new locus (CACNA1A rs4926244)
and increased susceptibility to XFS (odds ratio (OR) = 1.16,
P = 3.36 Ă 10â11). Although we also confirmed overwhelming
association at the LOXL1 locus, the key SNP marker (LOXL1
rs4886776) demonstrated allelic reversal depending on the
ancestry group (Japanese: ORA allele = 9.87, P = 2.13 Ă 10â217;
non-Japanese: ORA allele = 0.49, P = 2.35 Ă 10â31). Our findings
represent the first genetic locus outside of LOXL1 surpassing
genome-wide significance for XFS and provide insight into
the biology and pathogenesis of the disease